SCHEMBL8676997

SCHEMBL8676997

CCOc1cccc(-c2nc(-c3ccccc3)ccc2-c2ccc(OC)cc2)c1N1CCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.43
KDM4E B2RXH2 5/20 0.43
TSHR P16473 2/20 0.43
PKM P14618 2/20 0.43
MAPT P10636 6/20 0.41
KMT2A Q03164 6/20 0.41
ADORA3 P0DMS8 1/20 0.40
HPGD P15428 5/20 0.40
HSD17B10 Q99714 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
CASP1 P29466 3/20 0.40
CASP7 P55210 3/20 0.40
MAPK1 P28482 2/20 0.40
NTSR1 P30989 1/20 0.40
TP53 P04637 2/20 0.39
LMNA P02545 1/20 0.39
ATM Q13315 1/20 0.39
MEN1 O00255 4/20 0.39
NPSR1 Q6W5P4 4/20 0.39
HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8675940 0.97 ALDH1A1 (0.43) ALDH1A1KDM4ETSHRPKMMAPT
SCHEMBL8677539 0.92 MAPT (0.43) ALDH1A1KDM4ETSHRPKMMAPT
SCHEMBL8827945 0.90 ESR1 (0.40) ALDH1A1MAPTKMT2AHPGDHSD17B10
SCHEMBL8827914 0.87 ALDH1A1 (0.38) ALDH1A1MAPTKMT2AHPGDHSD17B10
SCHEMBL8678772 0.87 ADORA3 (0.42) ALDH1A1KDM4ETSHRPKMMAPT
SCHEMBL8677612 0.86 ADORA3 (0.41) ALDH1A1KDM4ETSHRPKMMAPT
SCHEMBL8827929 0.82 GRIA1 (0.39) ALDH1A1MAPTKMT2ASMN1; SMN2LMNA
SCHEMBL8677205 0.79 PRKDC (0.45) ALDH1A1KDM4EMAPTKMT2AADORA3
SCHEMBL8827923 0.76 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTKMT2AHPGD
SCHEMBL8827939 0.76 ALDH1A1 (0.40) ALDH1A1KDM4ETSHRMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750708-A Pyridine compounds intermediates processes compositions and methods ELI LILLY AND COMPANY (US) 1998-05-12 US disclosed
US-5672609-A POSTMENOPAUSAL SYNDROME; ANTILIPEMIC AND -CARCINOGENIC AGENTS; OSTEOPOROSIS; CARDIOTONIC AGENTS; RESTENOSIS; SIDE EFFECT REDUCTION COMPARED TO ESTROGEN ELI LILLY AND COMPANY (US) 1997-09-30 US disclosed